Blood filter trial offers new hope for chronic fatigue sufferers
NCT ID NCT05710770
First seen Jan 20, 2026 · Last updated May 24, 2026 · Updated 22 times
Summary
This study tested whether a blood-filtering procedure called immunoadsorption can reduce fatigue and other symptoms in people with chronic fatigue syndrome (ME/CFS), including those whose condition started after COVID-19. 66 adults with confirmed autoantibodies received either the real treatment or a sham procedure over 10 days, then were followed for 6 months. The goal was to see if removing certain immune particles from the blood could safely ease their symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ME/CFS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Charité - Universitätsmedizin Berlin
Berlin, State of Berlin, 10117, Germany
Conditions
Explore the condition pages connected to this study.